Agios Pharmaceuticals Inc (NASDAQ: AGIO): Is Its Value Too High Compared To Others?

AMAT

Agios Pharmaceuticals Inc (NASDAQ:AGIO) shares, rose in value, with the stock price up by 1.92% to the previous day’s close as strong demand from buyers drove the stock to $27.66.

Actively observing the price movement in the last trading, the stock closed the session at $27.14, falling within a range of $26.988 and $28.3787. The value of beta (5-year monthly) was 0.828 whereas the PE ratio was 2.43 over 12-month period. Referring to stock’s 52-week performance, its high was $62.58, and the low was $23.42. On the whole, AGIO has fluctuated by -12.69% over the past month.

With the market capitalization of Agios Pharmaceuticals Inc currently standing at about $1.58 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-12.

Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 51M, with a low estimate of 8.99M and a high estimate of 10.4M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 9.73M.

Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that AGIO’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.

The stock’s technical analysis shows that the price of AGIO currently trading nearly -1.80% and -11.42% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 44.94, while the 7-day volatility ratio is showing 4.99% which for the 30-day chart, stands at 6.45%. Furthermore, Agios Pharmaceuticals Inc (AGIO)’s beta value is 0.79, and its average true range (ATR) is 1.72.

A comparison of Agios Pharmaceuticals Inc (AGIO) with its peers suggests the former has fared considerably weaker in the market. AGIO showed an intraday change of 1.92% in last session, and over the past year, it shrunk by -3.96%%.

Data on historical trading for Agios Pharmaceuticals Inc (NASDAQ:AGIO) indicates that the trading volumes over the past 10 days have averaged 0.8 and over the past 3 months, they’ve averaged 694.34K. According to company’s latest data on outstanding shares, there are 57.16 million shares outstanding.

Nearly 3.72% of Agios Pharmaceuticals Inc’s shares belong to company insiders and institutional investors own 106.74% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 3.55 million shares as on 2025-03-31, resulting in a short ratio of 5.51. According to the data, the short interest in Agios Pharmaceuticals Inc (AGIO) stood at 628.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 3.94 million. The stock has fallen by -15.82% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the AGIO stock heading into the next quarter.

Most Popular